The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor James Lindsay which took place on Tuesday 13th March 2018 and addressed "Exploring the ‘ologies’ of Crohn’s disease: microbiology, immunology and stem-cell biology"
14 March 2018
James Lindsay is the Professor of Inflammatory Bowel Disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a Consultant Gastroenterologist at Barts Health NHS Trust. Along with a full multidisciplinary team he leads the adolescent and adult IBD service at The Royal London Hospital.
He is the Education Officer and a member of the Governing Board of the European Crohn’s and Colitis Organisation (ECCO) and has led development of National and International guidelines on the management of IBD.
He is Chief Investigator for a series of investigator-led and pharmaceutical clinical trials in IBD. He leads the NIHR funded ASTIClite trial which will assess the efficacy, safety and mechanism of action of low intensity autologous stem cell transplantation in patients with refractory Crohn’s disease. His translational research programme investigates manipulation of the microbiota, intestinal immune system and epigenetic control of gene expression to modify intestinal inflammation and fibrosis in Crohn’s disease.
He has published over 90 papers in journals including The Lancet, JAMA, Gastroenterology and Gut and has generated at least £5 million in research income from research councils and charities.